The rounds this investor is named on, who it invests beside, and where it shows up.
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Nouscom Nouscom is a biotech company selling cancer-preventing vaccine candidates primarily to healthcare providers and clinical trial organizations. | Series D Verified against 4 of 10 sources | $133.8M | 2026-10-19 | [ PART ] |
Nouscom A clinical-stage, cancer interception focused biotech developing next-generation immunotherapies | Series D |
| $134.7M |
| 2026-10-19 |
| [ PART ] |
Morphotonics A Dutch nanoimprint lithography (NIL) startup | Series B Verified against 4 of 22 sources | $45.5M | 2026-09-22 | [ PART ] |
HighLife HighLife develops a transcatheter system for replacing the mitral valve in patients with heart valve disease. | Funding round Verified against 4 of 9 sources | $90M | 2026-09-22 | [ PART ] |
NEURA Robotics NEURA Robotics sells humanoid robots and related AI technology primarily to industries requiring automation solutions. | Series C Verified against 1 of 5 sources[ REPORTED LATER ]: This round was announced before Fireround first saw it. It stays in the company's history, not in Latest, Trending, or alerts. | $1.4B | 2026-06-10 | [ PART ] |
Qonto Qonto sells online business accounts and financial management tools aimed at small businesses, freelancers, and entrepreneurs. | Funding round Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $23.5M | 2018-09-24 | [ PART ] |